Biologic Drugs Market Report

Global Biologic Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：May 11, 2021
  • PAGES：176
  • REPORT CODE：GMM661732
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Biologic Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Biologic Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Biologic Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Biologic Drugs Market Segmentations:

    By Players:

    • Pfizer

    • Novartis

    • Abbott Laboratories

    • Eli Lilly

    • Merck & Co

    • Johnson & Johnson

    • Amgen

    • Roche

    • Sanofi

    By Types:

    • Humira

    • Remicade

    • Rituxan

    • Enbrel

    • Lantus

    • Avastin

    • Herceptin

    • Others

    By End-User:

    • Diabetes

    • Inflammation

    • Auto-Immune Diseases

    • Blood Diseases

    • Cardiovascular Diseases

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologic Drugs Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Biologic Drugs Market Size and Growth Rate of Humira from 2014 to 2026

      • 1.3.2 Global Biologic Drugs Market Size and Growth Rate of Remicade from 2014 to 2026

      • 1.3.3 Global Biologic Drugs Market Size and Growth Rate of Rituxan from 2014 to 2026

      • 1.3.4 Global Biologic Drugs Market Size and Growth Rate of Enbrel from 2014 to 2026

      • 1.3.5 Global Biologic Drugs Market Size and Growth Rate of Lantus from 2014 to 2026

      • 1.3.6 Global Biologic Drugs Market Size and Growth Rate of Avastin from 2014 to 2026

      • 1.3.7 Global Biologic Drugs Market Size and Growth Rate of Herceptin from 2014 to 2026

      • 1.3.8 Global Biologic Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Biologic Drugs Market Size and Growth Rate of Diabetes from 2014 to 2026

      • 1.4.2 Global Biologic Drugs Market Size and Growth Rate of Inflammation from 2014 to 2026

      • 1.4.3 Global Biologic Drugs Market Size and Growth Rate of Auto-Immune Diseases from 2014 to 2026

      • 1.4.4 Global Biologic Drugs Market Size and Growth Rate of Blood Diseases from 2014 to 2026

      • 1.4.5 Global Biologic Drugs Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

      • 1.4.6 Global Biologic Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Biologic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Biologic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Biologic Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Biologic Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Biologic Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Biologic Drugs Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Biologic Drugs by Major Types

      • 3.4.1 Biologic Drugs Market Size and Growth Rate of Humira

      • 3.4.2 Biologic Drugs Market Size and Growth Rate of Remicade

      • 3.4.3 Biologic Drugs Market Size and Growth Rate of Rituxan

      • 3.4.4 Biologic Drugs Market Size and Growth Rate of Enbrel

      • 3.4.5 Biologic Drugs Market Size and Growth Rate of Lantus

      • 3.4.6 Biologic Drugs Market Size and Growth Rate of Avastin

      • 3.4.7 Biologic Drugs Market Size and Growth Rate of Herceptin

      • 3.4.8 Biologic Drugs Market Size and Growth Rate of Others

    4 Segmentation of Biologic Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Biologic Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Biologic Drugs in Diabetes

      • 4.4.2 Market Size and Growth Rate of Biologic Drugs in Inflammation

      • 4.4.3 Market Size and Growth Rate of Biologic Drugs in Auto-Immune Diseases

      • 4.4.4 Market Size and Growth Rate of Biologic Drugs in Blood Diseases

      • 4.4.5 Market Size and Growth Rate of Biologic Drugs in Cardiovascular Diseases

      • 4.4.6 Market Size and Growth Rate of Biologic Drugs in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Biologic Drugs Production Analysis by Major Regions

    • 5.2 Global Biologic Drugs Consumption Analysis by Major Regions

    • 5.3 Global Biologic Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Biologic Drugs Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Biologic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Biologic Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Biologic Drugs Production, Import, Consumption and Export Analysis

    6 Product Commodity of Biologic Drugs Market in Major Countries

    • 6.1 Top 5 Export Countries in Biologic Drugs market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Biologic Drugs market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Biologic Drugs market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Biologic Drugs market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Biologic Drugs market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Biologic Drugs market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Biologic Drugs Landscape Analysis

    • 7.1 North America Biologic Drugs Landscape Analysis by Major Types

    • 7.2 North America Biologic Drugs Landscape Analysis by Major End-Users

    • 7.3 North America Biologic Drugs Landscape Analysis by Major Countries

      • 7.3.1 United States Biologic Drugs Market Volume and Growth Rate

      • 7.3.2 Canada Biologic Drugs Market Volume and Growth Rate

      • 7.3.3 Mexico Biologic Drugs Market Volume and Growth Rate

    8 Europe Biologic Drugs Landscape Analysis

    • 8.1 Europe Biologic Drugs Landscape Analysis by Major Types

    • 8.2 Europe Biologic Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe Biologic Drugs Landscape Analysis by Major Countries

      • 8.3.1 Germany Biologic Drugs Market Volume and Growth Rate

      • 8.3.2 UK Biologic Drugs Market Volume and Growth Rate

      • 8.3.3 France Biologic Drugs Market Volume and Growth Rate

      • 8.3.4 Italy Biologic Drugs Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Biologic Drugs Market Volume and Growth Rate

      • 8.3.6 Spain Biologic Drugs Market Volume and Growth Rate

      • 8.3.7 Belgium Biologic Drugs Market Volume and Growth Rate

      • 8.3.8 Poland Biologic Drugs Market Volume and Growth Rate

      • 8.3.9 Russia Biologic Drugs Market Volume and Growth Rate

      • 8.3.10 Turkey Biologic Drugs Market Volume and Growth Rate

    9 Asia Pacific Biologic Drugs Landscape Analysis

    • 9.1 Asia Pacific Biologic Drugs Landscape Analysis by Major Types

    • 9.2 Asia Pacific Biologic Drugs Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Biologic Drugs Landscape Analysis by Major Countries

      • 9.3.1 China Biologic Drugs Market Volume and Growth Rate

      • 9.3.2 Japan Biologic Drugs Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Biologic Drugs Market Volume and Growth Rate

      • 9.3.4 India Biologic Drugs Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Biologic Drugs Market Volume and Growth Rate

      • 9.3.6 South Korea Biologic Drugs Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Biologic Drugs Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Biologic Drugs Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Biologic Drugs Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Biologic Drugs Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Biologic Drugs Market Volume and Growth Rate

      • 10.3.2 Brazil Biologic Drugs Market Volume and Growth Rate

      • 10.3.3 Nigeria Biologic Drugs Market Volume and Growth Rate

      • 10.3.4 South Africa Biologic Drugs Market Volume and Growth Rate 

      • 10.3.5 Argentina Biologic Drugs Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Pfizer

      • 11.1.1 Pfizer Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Novartis

      • 11.2.1 Novartis Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Abbott Laboratories

      • 11.3.1 Abbott Laboratories Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Eli Lilly

      • 11.4.1 Eli Lilly Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Merck & Co

      • 11.5.1 Merck & Co Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Johnson & Johnson

      • 11.6.1 Johnson & Johnson Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Amgen

      • 11.7.1 Amgen Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Roche

      • 11.8.1 Roche Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Sanofi

      • 11.9.1 Sanofi Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 122 Figures and 159 Tables)

    • Figure Product Picture

    • Figure Biologic Drugs Market Size and Growth Rate of Humira from 2014 to 2026

    • Figure Biologic Drugs Market Size and Growth Rate of Remicade from 2014 to 2026

    • Figure Biologic Drugs Market Size and Growth Rate of Rituxan from 2014 to 2026

    • Figure Biologic Drugs Market Size and Growth Rate of Enbrel from 2014 to 2026

    • Figure Biologic Drugs Market Size and Growth Rate of Lantus from 2014 to 2026

    • Figure Biologic Drugs Market Size and Growth Rate of Avastin from 2014 to 2026

    • Figure Biologic Drugs Market Size and Growth Rate of Herceptin from 2014 to 2026

    • Figure Biologic Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Biologic Drugs Market Size and Growth Rate of Diabetes from 2014 to 2026

    • Figure Global Biologic Drugs Market Size and Growth Rate of Inflammation from 2014 to 2026

    • Figure Global Biologic Drugs Market Size and Growth Rate of Auto-Immune Diseases from 2014 to 2026

    • Figure Global Biologic Drugs Market Size and Growth Rate of Blood Diseases from 2014 to 2026

    • Figure Global Biologic Drugs Market Size and Growth Rate of Cardiovascular Diseases from 2014 to 2026

    • Figure Global Biologic Drugs Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Biologic Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Biologic Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Biologic Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Biologic Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Biologic Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Humira

    • Figure Market Size and Growth Rate of Remicade

    • Figure Market Size and Growth Rate of Rituxan

    • Figure Market Size and Growth Rate of Enbrel

    • Figure Market Size and Growth Rate of Lantus

    • Figure Market Size and Growth Rate of Avastin

    • Figure Market Size and Growth Rate of Herceptin

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Biologic Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Biologic Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Diabetes

    • Figure Market Size and Growth Rate of Inflammation

    • Figure Market Size and Growth Rate of Auto-Immune Diseases

    • Figure Market Size and Growth Rate of Blood Diseases

    • Figure Market Size and Growth Rate of Cardiovascular Diseases

    • Figure Market Size and Growth Rate of Others

    • Table Global Biologic Drugs Production by Major Regions

    • Table Global Biologic Drugs Production Share by Major Regions

    • Figure Global Biologic Drugs Production Share by Major Regions in 2014

    • Figure Global Biologic Drugs Production Share by Major Regions in 2018

    • Figure Global Biologic Drugs Production Share by Major Regions in 2026

    • Table Global Biologic Drugs Consumption by Major Regions

    • Table Global Biologic Drugs Consumption Share by Major Regions

    • Figure Global Biologic Drugs Consumption Share by Major Regions in 2014

    • Figure Global Biologic Drugs Consumption Share by Major Regions in 2018

    • Figure Global Biologic Drugs Consumption Share by Major Regions in 2026

    • Table North America Biologic Drugs Production, Import, Consumption and Export Analysis

    • Table Europe Biologic Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Biologic Drugs Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Biologic Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Biologic Drugs market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Biologic Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Biologic Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Biologic Drugs market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Biologic Drugs Consumption by Types from 2014 to 2026

    • Table North America Biologic Drugs Consumption Share by Types from 2014 to 2026

    • Figure North America Biologic Drugs Consumption Share by Types in 2014

    • Figure North America Biologic Drugs Consumption Share by Types in 2018

    • Figure North America Biologic Drugs Consumption Share by Types in 2026

    • Table North America Biologic Drugs Consumption by End-Users from 2014 to 2026

    • Table North America Biologic Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure North America Biologic Drugs Consumption Share by End-Users in 2014

    • Figure North America Biologic Drugs Consumption Share by End-Users in 2018

    • Figure North America Biologic Drugs Consumption Share by End-Users in 2026

    • Table North America Biologic Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America Biologic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Biologic Drugs Consumption Share by Major Countries in 2014

    • Figure North America Biologic Drugs Consumption Share by Major Countries in 2018

    • Figure North America Biologic Drugs Consumption Share by Major Countries in 2026

    • Figure United States Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Biologic Drugs Consumption by Types from 2014 to 2026

    • Table Europe Biologic Drugs Consumption Share by Types from 2014 to 2026

    • Figure Europe Biologic Drugs Consumption Share by Types in 2014

    • Figure Europe Biologic Drugs Consumption Share by Types in 2018

    • Figure Europe Biologic Drugs Consumption Share by Types in 2026

    • Table Europe Biologic Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe Biologic Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Biologic Drugs Consumption Share by End-Users in 2014

    • Figure Europe Biologic Drugs Consumption Share by End-Users in 2018

    • Figure Europe Biologic Drugs Consumption Share by End-Users in 2026

    • Table Europe Biologic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe Biologic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Biologic Drugs Consumption Share by Major Countries in 2014

    • Figure Europe Biologic Drugs Consumption Share by Major Countries in 2018

    • Figure Europe Biologic Drugs Consumption Share by Major Countries in 2026

    • Figure Germany Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Biologic Drugs Consumption by Types from 2014 to 2026

    • Table Asia Pacific Biologic Drugs Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Biologic Drugs Consumption Share by Types in 2014

    • Figure Asia Pacific Biologic Drugs Consumption Share by Types in 2018

    • Figure Asia Pacific Biologic Drugs Consumption Share by Types in 2026

    • Table Asia Pacific Biologic Drugs Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Biologic Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Biologic Drugs Consumption Share by End-Users in 2014

    • Figure Asia Pacific Biologic Drugs Consumption Share by End-Users in 2018

    • Figure Asia Pacific Biologic Drugs Consumption Share by End-Users in 2026

    • Table Asia Pacific Biologic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Biologic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Biologic Drugs Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Biologic Drugs Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Biologic Drugs Consumption Share by Major Countries in 2026

    • Figure China Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandBiologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologic Drugs Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologic Drugs Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Biologic Drugs Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologic Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Biologic Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Biologic Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Biologic Drugs Consumption Share by Major Countries in 2026

    • Figure GCC Countries Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Biologic Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

    • Table Company Profile and Development Status of Merck & Co

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co

    • Figure Sales and Growth Rate Analysis of Merck & Co

    • Figure Revenue and Market Share Analysis of Merck & Co

    • Table Product and Service Introduction of Merck & Co

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Sanofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi

    • Figure Sales and Growth Rate Analysis of Sanofi

    • Figure Revenue and Market Share Analysis of Sanofi

    • Table Product and Service Introduction of Sanofi


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US